Form UPLOAD - SEC-generated letter:
SEC Accession No. 0000000000-23-009355
Filing Date
2023-08-24
Accepted
2023-08-24 17:30:06
Documents
2

Document Format Files

Seq Description Document Type Size
1 filename1.pdf LETTER 27640
2 filename2.txt TEXT-EXTRACT 1479
  Complete submission text file 0000000000-23-009355.txt   40393
Mailing Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807
Business Address 400 CROSSING BOULEVARD BRIDGEWATER NJ 08807 9088091300
RVL Pharmaceuticals plc (Filed for) CIK: 0001739426 (see all company filings)

EIN.: 000000000 | State of Incorp.: L2 | Fiscal Year End: 1231
Type: UPLOAD
SIC: 2834 Pharmaceutical Preparations